Gen-Wealth Partners’s Caribou Biosciences CRBU Stock Holding History

Gen-Wealth Partners’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$239	Hold	136	–	–	﹤0.01%	705
2026 Q1	$258	Hold	136	–	–	﹤0.01%	710
2025 Q4	$216	Hold	136	–	–	﹤0.01%	679
2025 Q3	$317	Hold	136	–	–	﹤0.01%	669
2025 Q2	$171	Hold	136	–	–	﹤0.01%	634
2025 Q1	$124	Hold	136	–	–	﹤0.01%	610
2024 Q4	$216	Hold	136	–	–	﹤0.01%	639
2024 Q3	$268	Hold	136	–	–	﹤0.01%	647
2024 Q2	$223	Hold	136	–	–	﹤0.01%	633
2024 Q1	$699	Buy	+136	New	+$839	﹤0.01%	592

Other funds holding CRBU

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gen-Wealth Partners's CRBU Position: Q2 2026 in Review

Gen-Wealth Partners held its Caribou Biosciences (CRBU) position steady in Q2 2026 at 136 shares worth $239. The position accounts for ﹤0.01% of the portfolio, ranked #705.

Gen-Wealth Partners first reported a position in CRBU in Q1 2024 and has held it in 10 quarters since. The position peaked at $699 in Q1 2024. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

Gen-Wealth Partners held 136 shares of Caribou Biosciences worth $239 as of Q2 2026.
Gen-Wealth Partners left its Caribou Biosciences share count unchanged in Q2 2026.
Caribou Biosciences made up ﹤0.01% of Gen-Wealth Partners's portfolio in Q2 2026, its #705 holding.
Gen-Wealth Partners first reported a position in Caribou Biosciences in Q1 2024 and has held it in 10 quarters since.
Gen-Wealth Partners's Caribou Biosciences position peaked at $699 in Q1 2024.
137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Gen-Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.